Obesity 2016: Minimally Invasive Bariatric Devices Gaining Steam
Executive Summary
With no end in sight for the obesity epidemic, there is a vast and underserved market opportunity for manufacturers developing minimally invasive solutions for obesity that can fill the treatment gap between invasive bariatric surgery and conservative weight loss methods (diet, exercise, and drugs). Despite some high-profile setbacks in the last few years, the market for minimally invasive bariatric devices is gaining steam as several companies have recently launched obesity devices on the US market while others have completed clinical trials and are advancing toward US regulatory approval.
You may also be interested in...
Market Intel: Intragastric Balloons And Other Innovations To Inflate Weight Loss Devices Market
The global market for minimally invasive weight loss devices is expected to grow to $290m by 2021, a CAGR of 16%, driven in large part by the rising obesity epidemic and associated Type 2 diabetes. Meddevicetracker expects that enhancements and innovations, particularly in the growing intragastric balloon market, and emerging technologies by smaller companies, will lead the growth in the overall weight loss devices market. In this feature, we'll take a closer look at the overall market and regional landscape and take a deep dive into the fastest-growing intragastric balloon segment, providing key insights from a bariatric surgeon on the pros and cons of these technologies.
CMS Advisors Say More Evidence Needed For Obesity Surgery
Bariatric surgery may offer good results for younger patients, but CMS advisors felt the evidence wasn’t there to guarantee successful results for older patients on Medicare.
US FDA Warns of Deaths Tied To Gastric Balloons
The agency doesn’t yet know the exact causes of the five deaths. This is the second safety alert on the obesity-treatment devices this year.